Fluorine in PDB 1gsz: Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Enzymatic activity of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
All present enzymatic activity of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071:
5.4.99.17;
Protein crystallography data
The structure of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071, PDB code: 1gsz
was solved by
A.Lenhart,
W.A.Weihofen,
A.E.W.Pleschke,
G.E.Schulz,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
25.00 /
2.80
|
Space group
|
P 32 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
140.897,
140.897,
244.049,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
20.3 /
25.9
|
Other elements in 1gsz:
The structure of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
(pdb code 1gsz). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071, PDB code: 1gsz:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 1gsz
Go back to
Fluorine Binding Sites List in 1gsz
Fluorine binding site 1 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1630
b:19.6
occ:0.62
|
F22
|
A:R711630
|
0.0
|
19.6
|
0.6
|
C6
|
A:R711630
|
1.3
|
19.6
|
0.6
|
C2
|
A:R711630
|
1.6
|
19.2
|
0.4
|
C3
|
A:R711630
|
2.2
|
19.2
|
0.4
|
C5
|
A:R711630
|
2.4
|
19.6
|
0.6
|
C1
|
A:R711630
|
2.4
|
19.6
|
0.6
|
C1
|
A:R711630
|
2.6
|
19.2
|
0.4
|
O21
|
A:R711630
|
2.8
|
55.5
|
0.6
|
C7
|
A:R711630
|
3.0
|
55.5
|
0.6
|
O21
|
A:R711630
|
3.1
|
50.3
|
0.4
|
C7
|
A:R711630
|
3.3
|
50.3
|
0.4
|
C4
|
A:R711630
|
3.4
|
19.2
|
0.4
|
CG
|
A:PRO263
|
3.6
|
8.2
|
1.0
|
CZ
|
A:PHE605
|
3.6
|
41.9
|
1.0
|
C4
|
A:R711630
|
3.7
|
19.6
|
0.6
|
C6
|
A:R711630
|
3.7
|
19.2
|
0.4
|
CD
|
A:PRO263
|
3.7
|
8.2
|
1.0
|
C2
|
A:R711630
|
3.7
|
19.6
|
0.6
|
CE2
|
A:PHE605
|
3.7
|
41.9
|
1.0
|
C5
|
A:R711630
|
4.0
|
19.2
|
0.4
|
CB
|
A:ALA306
|
4.1
|
9.0
|
1.0
|
C3
|
A:R711630
|
4.2
|
19.6
|
0.6
|
CE
|
A:MET42
|
4.3
|
18.9
|
1.0
|
CE1
|
A:PHE605
|
4.4
|
41.9
|
1.0
|
O14
|
A:R711630
|
4.4
|
41.7
|
0.4
|
C8
|
A:R711630
|
4.4
|
55.5
|
0.6
|
SD
|
A:MET42
|
4.5
|
18.9
|
1.0
|
OE1
|
A:GLN262
|
4.5
|
11.5
|
1.0
|
CD2
|
A:PHE605
|
4.6
|
41.9
|
1.0
|
C8
|
A:R711630
|
4.7
|
50.3
|
0.4
|
O
|
A:ALA306
|
4.8
|
23.0
|
1.0
|
O14
|
A:R711630
|
4.8
|
41.7
|
0.6
|
CB
|
A:GLN262
|
4.8
|
11.5
|
1.0
|
F22
|
A:R711630
|
4.8
|
19.2
|
0.4
|
CA
|
A:ALA306
|
4.8
|
23.0
|
1.0
|
O
|
A:HOH2010
|
4.9
|
20.0
|
1.0
|
N
|
A:PRO263
|
4.9
|
8.0
|
1.0
|
N
|
A:GLN262
|
4.9
|
5.3
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 1gsz
Go back to
Fluorine Binding Sites List in 1gsz
Fluorine binding site 2 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1630
b:19.2
occ:0.38
|
F22
|
A:R711630
|
0.0
|
19.2
|
0.4
|
C6
|
A:R711630
|
1.3
|
19.2
|
0.4
|
C2
|
A:R711630
|
1.9
|
19.6
|
0.6
|
C9
|
A:R711630
|
2.2
|
55.5
|
0.6
|
C5
|
A:R711630
|
2.3
|
19.2
|
0.4
|
C1
|
A:R711630
|
2.4
|
19.2
|
0.4
|
C1
|
A:R711630
|
2.6
|
19.6
|
0.6
|
C8
|
A:R711630
|
2.6
|
55.5
|
0.6
|
C3
|
A:R711630
|
2.8
|
19.6
|
0.6
|
C7
|
A:R711630
|
2.9
|
55.5
|
0.6
|
CB
|
A:TRP169
|
3.0
|
12.0
|
1.0
|
C7
|
A:R711630
|
3.0
|
50.3
|
0.4
|
C8
|
A:R711630
|
3.0
|
50.3
|
0.4
|
C10
|
A:R711630
|
3.1
|
55.5
|
0.6
|
C9
|
A:R711630
|
3.2
|
50.3
|
0.4
|
CG
|
A:TRP169
|
3.2
|
12.0
|
1.0
|
CD1
|
A:TRP169
|
3.3
|
12.0
|
1.0
|
C4
|
A:R711630
|
3.7
|
19.2
|
0.4
|
C2
|
A:R711630
|
3.7
|
19.2
|
0.4
|
C13
|
A:R711630
|
3.7
|
55.5
|
0.6
|
C6
|
A:R711630
|
3.8
|
19.6
|
0.6
|
CZ
|
A:PHE601
|
3.8
|
28.9
|
1.0
|
CD1
|
A:ILE261
|
3.9
|
36.4
|
1.0
|
C13
|
A:R711630
|
3.9
|
50.3
|
0.4
|
C4
|
A:R711630
|
3.9
|
19.6
|
0.6
|
C10
|
A:R711630
|
4.1
|
50.3
|
0.4
|
C11
|
A:R711630
|
4.1
|
55.5
|
0.6
|
CA
|
A:TRP169
|
4.1
|
11.8
|
1.0
|
C3
|
A:R711630
|
4.2
|
19.2
|
0.4
|
CE2
|
A:PHE601
|
4.2
|
28.9
|
1.0
|
O21
|
A:R711630
|
4.3
|
55.5
|
0.6
|
C5
|
A:R711630
|
4.3
|
19.6
|
0.6
|
C
|
A:TRP169
|
4.3
|
11.8
|
1.0
|
CD2
|
A:TRP169
|
4.3
|
12.0
|
1.0
|
NE1
|
A:TRP169
|
4.3
|
12.0
|
1.0
|
O21
|
A:R711630
|
4.4
|
50.3
|
0.4
|
C12
|
A:R711630
|
4.4
|
55.5
|
0.6
|
O
|
A:TRP169
|
4.4
|
11.8
|
1.0
|
CG
|
A:PRO263
|
4.6
|
8.2
|
1.0
|
C12
|
A:R711630
|
4.7
|
50.3
|
0.4
|
C11
|
A:R711630
|
4.7
|
50.3
|
0.4
|
O14
|
A:R711630
|
4.8
|
41.7
|
0.4
|
F22
|
A:R711630
|
4.8
|
19.6
|
0.6
|
CE2
|
A:TRP169
|
4.9
|
12.0
|
1.0
|
CE1
|
A:PHE601
|
5.0
|
28.9
|
1.0
|
N
|
A:ALA170
|
5.0
|
22.0
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 1gsz
Go back to
Fluorine Binding Sites List in 1gsz
Fluorine binding site 3 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1630
b:12.8
occ:0.62
|
F22
|
B:R711630
|
0.0
|
12.8
|
0.6
|
C6
|
B:R711630
|
1.3
|
12.8
|
0.6
|
C2
|
B:R711630
|
1.5
|
22.0
|
0.4
|
C5
|
B:R711630
|
2.4
|
12.8
|
0.6
|
C3
|
B:R711630
|
2.4
|
22.0
|
0.4
|
C1
|
B:R711630
|
2.4
|
12.8
|
0.6
|
C1
|
B:R711630
|
2.5
|
22.0
|
0.4
|
O21
|
B:R711630
|
2.9
|
49.6
|
0.6
|
O21
|
B:R711630
|
2.9
|
33.6
|
0.4
|
C7
|
B:R711630
|
3.0
|
49.6
|
0.6
|
C7
|
B:R711630
|
3.0
|
33.6
|
0.4
|
CG
|
B:PRO263
|
3.3
|
1.3
|
1.0
|
CD
|
B:PRO263
|
3.5
|
1.3
|
1.0
|
C4
|
B:R711630
|
3.6
|
22.0
|
0.4
|
C4
|
B:R711630
|
3.7
|
12.8
|
0.6
|
C6
|
B:R711630
|
3.7
|
22.0
|
0.4
|
C2
|
B:R711630
|
3.7
|
12.8
|
0.6
|
CZ
|
B:PHE605
|
3.8
|
16.6
|
1.0
|
CE2
|
B:PHE605
|
3.9
|
16.6
|
1.0
|
C5
|
B:R711630
|
4.1
|
22.0
|
0.4
|
C3
|
B:R711630
|
4.2
|
12.8
|
0.6
|
OE1
|
B:GLN262
|
4.3
|
9.0
|
1.0
|
CE
|
B:MET42
|
4.3
|
12.6
|
1.0
|
C8
|
B:R711630
|
4.4
|
33.6
|
0.4
|
C8
|
B:R711630
|
4.4
|
49.6
|
0.6
|
CE1
|
B:PHE605
|
4.5
|
16.6
|
1.0
|
CB
|
B:ALA306
|
4.5
|
12.5
|
1.0
|
SD
|
B:MET42
|
4.5
|
12.6
|
1.0
|
CD2
|
B:PHE605
|
4.6
|
16.6
|
1.0
|
O14
|
B:R711630
|
4.7
|
41.7
|
0.4
|
N
|
B:PRO263
|
4.7
|
14.4
|
1.0
|
F22
|
B:R711630
|
4.8
|
22.0
|
0.4
|
CB
|
B:PRO263
|
4.8
|
1.3
|
1.0
|
O14
|
B:R711630
|
4.8
|
41.7
|
0.6
|
CB
|
B:GLN262
|
4.8
|
9.0
|
1.0
|
C9
|
B:R711630
|
4.8
|
33.6
|
0.4
|
O
|
B:HOH2008
|
4.9
|
13.7
|
1.0
|
C9
|
B:R711630
|
5.0
|
49.6
|
0.6
|
O
|
B:ALA306
|
5.0
|
14.1
|
1.0
|
N
|
B:GLN262
|
5.0
|
9.1
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 1gsz
Go back to
Fluorine Binding Sites List in 1gsz
Fluorine binding site 4 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1630
b:22.0
occ:0.38
|
F22
|
B:R711630
|
0.0
|
22.0
|
0.4
|
C6
|
B:R711630
|
1.3
|
22.0
|
0.4
|
C2
|
B:R711630
|
1.5
|
12.8
|
0.6
|
C5
|
B:R711630
|
2.4
|
22.0
|
0.4
|
C3
|
B:R711630
|
2.4
|
12.8
|
0.6
|
C1
|
B:R711630
|
2.4
|
22.0
|
0.4
|
C1
|
B:R711630
|
2.5
|
12.8
|
0.6
|
C8
|
B:R711630
|
2.8
|
49.6
|
0.6
|
C9
|
B:R711630
|
2.9
|
49.6
|
0.6
|
C7
|
B:R711630
|
3.0
|
49.6
|
0.6
|
C7
|
B:R711630
|
3.0
|
33.6
|
0.4
|
C8
|
B:R711630
|
3.0
|
33.6
|
0.4
|
CB
|
B:TRP169
|
3.1
|
12.7
|
1.0
|
CG
|
B:TRP169
|
3.2
|
12.7
|
1.0
|
C9
|
B:R711630
|
3.2
|
33.6
|
0.4
|
CD1
|
B:TRP169
|
3.3
|
12.7
|
1.0
|
CZ
|
B:PHE601
|
3.4
|
27.6
|
1.0
|
C4
|
B:R711630
|
3.6
|
12.8
|
0.6
|
C13
|
B:R711630
|
3.6
|
49.6
|
0.6
|
C4
|
B:R711630
|
3.7
|
22.0
|
0.4
|
C6
|
B:R711630
|
3.7
|
12.8
|
0.6
|
C2
|
B:R711630
|
3.7
|
22.0
|
0.4
|
C10
|
B:R711630
|
3.7
|
49.6
|
0.6
|
CE2
|
B:PHE601
|
3.8
|
27.6
|
1.0
|
C13
|
B:R711630
|
3.8
|
33.6
|
0.4
|
C5
|
B:R711630
|
4.1
|
12.8
|
0.6
|
C10
|
B:R711630
|
4.1
|
33.6
|
0.4
|
C3
|
B:R711630
|
4.2
|
22.0
|
0.4
|
CD1
|
B:ILE261
|
4.2
|
40.6
|
1.0
|
NE1
|
B:TRP169
|
4.2
|
12.7
|
1.0
|
CD2
|
B:TRP169
|
4.2
|
12.7
|
1.0
|
O21
|
B:R711630
|
4.3
|
33.6
|
0.4
|
O21
|
B:R711630
|
4.3
|
49.6
|
0.6
|
C12
|
B:R711630
|
4.3
|
49.6
|
0.6
|
C11
|
B:R711630
|
4.4
|
49.6
|
0.6
|
CA
|
B:TRP169
|
4.4
|
19.7
|
1.0
|
CE1
|
B:PHE601
|
4.6
|
27.6
|
1.0
|
C12
|
B:R711630
|
4.6
|
33.6
|
0.4
|
C
|
B:TRP169
|
4.7
|
19.7
|
1.0
|
CE2
|
B:TRP169
|
4.7
|
12.7
|
1.0
|
O14
|
B:R711630
|
4.7
|
41.7
|
0.6
|
C11
|
B:R711630
|
4.7
|
33.6
|
0.4
|
F22
|
B:R711630
|
4.8
|
12.8
|
0.6
|
O14
|
B:R711630
|
4.8
|
41.7
|
0.4
|
O
|
B:TRP169
|
4.8
|
19.7
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 1gsz
Go back to
Fluorine Binding Sites List in 1gsz
Fluorine binding site 5 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F1630
b:23.6
occ:0.62
|
F22
|
C:R711630
|
0.0
|
23.6
|
0.6
|
C2
|
C:R711630
|
1.2
|
42.9
|
0.4
|
C6
|
C:R711630
|
1.3
|
23.6
|
0.6
|
C3
|
C:R711630
|
2.3
|
42.9
|
0.4
|
C1
|
C:R711630
|
2.3
|
42.9
|
0.4
|
C5
|
C:R711630
|
2.4
|
23.6
|
0.6
|
C1
|
C:R711630
|
2.4
|
23.6
|
0.6
|
O21
|
C:R711630
|
2.6
|
55.8
|
0.4
|
O21
|
C:R711630
|
2.7
|
34.2
|
0.6
|
C7
|
C:R711630
|
2.8
|
55.8
|
0.4
|
C7
|
C:R711630
|
2.9
|
34.2
|
0.6
|
CZ
|
C:PHE605
|
3.4
|
16.5
|
1.0
|
CE2
|
C:PHE605
|
3.5
|
16.5
|
1.0
|
C4
|
C:R711630
|
3.6
|
42.9
|
0.4
|
C6
|
C:R711630
|
3.6
|
42.9
|
0.4
|
CG
|
C:PRO263
|
3.7
|
14.7
|
1.0
|
C4
|
C:R711630
|
3.7
|
23.6
|
0.6
|
C2
|
C:R711630
|
3.7
|
23.6
|
0.6
|
CD
|
C:PRO263
|
3.9
|
14.7
|
1.0
|
C5
|
C:R711630
|
4.1
|
42.9
|
0.4
|
CE1
|
C:PHE605
|
4.1
|
16.5
|
1.0
|
CD2
|
C:PHE605
|
4.2
|
16.5
|
1.0
|
C3
|
C:R711630
|
4.2
|
23.6
|
0.6
|
C8
|
C:R711630
|
4.2
|
55.8
|
0.4
|
CE
|
C:MET42
|
4.4
|
11.5
|
1.0
|
C8
|
C:R711630
|
4.4
|
34.2
|
0.6
|
CB
|
C:ALA306
|
4.5
|
1.0
|
1.0
|
OE1
|
C:GLN262
|
4.7
|
15.7
|
1.0
|
SD
|
C:MET42
|
4.7
|
11.5
|
1.0
|
F22
|
C:R711630
|
4.7
|
42.9
|
0.4
|
CD1
|
C:PHE605
|
4.7
|
16.5
|
1.0
|
O14
|
C:R711630
|
4.7
|
41.7
|
0.4
|
CG
|
C:PHE605
|
4.8
|
16.5
|
1.0
|
O14
|
C:R711630
|
4.8
|
41.7
|
0.6
|
C9
|
C:R711630
|
4.8
|
55.8
|
0.4
|
O
|
C:HOH2010
|
4.9
|
27.9
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 1gsz
Go back to
Fluorine Binding Sites List in 1gsz
Fluorine binding site 6 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F1630
b:42.9
occ:0.38
|
F22
|
C:R711630
|
0.0
|
42.9
|
0.4
|
C6
|
C:R711630
|
1.3
|
42.9
|
0.4
|
C2
|
C:R711630
|
1.3
|
23.6
|
0.6
|
C1
|
C:R711630
|
2.3
|
23.6
|
0.6
|
C5
|
C:R711630
|
2.4
|
42.9
|
0.4
|
C3
|
C:R711630
|
2.4
|
23.6
|
0.6
|
C1
|
C:R711630
|
2.4
|
42.9
|
0.4
|
C9
|
C:R711630
|
2.6
|
34.2
|
0.6
|
C8
|
C:R711630
|
2.7
|
34.2
|
0.6
|
C7
|
C:R711630
|
2.8
|
34.2
|
0.6
|
C7
|
C:R711630
|
3.0
|
55.8
|
0.4
|
C8
|
C:R711630
|
3.0
|
55.8
|
0.4
|
CZ
|
C:PHE601
|
3.1
|
25.4
|
1.0
|
CD1
|
C:TRP169
|
3.2
|
14.2
|
1.0
|
CG
|
C:TRP169
|
3.2
|
14.2
|
1.0
|
C9
|
C:R711630
|
3.3
|
55.8
|
0.4
|
CB
|
C:TRP169
|
3.3
|
14.2
|
1.0
|
CE2
|
C:PHE601
|
3.5
|
25.4
|
1.0
|
C10
|
C:R711630
|
3.6
|
34.2
|
0.6
|
C6
|
C:R711630
|
3.6
|
23.6
|
0.6
|
C4
|
C:R711630
|
3.7
|
42.9
|
0.4
|
C4
|
C:R711630
|
3.7
|
23.6
|
0.6
|
C2
|
C:R711630
|
3.7
|
42.9
|
0.4
|
C13
|
C:R711630
|
3.7
|
34.2
|
0.6
|
C13
|
C:R711630
|
3.7
|
55.8
|
0.4
|
NE1
|
C:TRP169
|
4.0
|
14.2
|
1.0
|
O21
|
C:R711630
|
4.1
|
34.2
|
0.6
|
C5
|
C:R711630
|
4.1
|
23.6
|
0.6
|
C10
|
C:R711630
|
4.1
|
55.8
|
0.4
|
CD2
|
C:TRP169
|
4.1
|
14.2
|
1.0
|
C3
|
C:R711630
|
4.2
|
42.9
|
0.4
|
O21
|
C:R711630
|
4.3
|
55.8
|
0.4
|
CE1
|
C:PHE601
|
4.3
|
25.4
|
1.0
|
C11
|
C:R711630
|
4.4
|
34.2
|
0.6
|
C12
|
C:R711630
|
4.5
|
34.2
|
0.6
|
CD1
|
C:ILE261
|
4.5
|
1.0
|
1.0
|
C12
|
C:R711630
|
4.5
|
55.8
|
0.4
|
CE2
|
C:TRP169
|
4.5
|
14.2
|
1.0
|
CA
|
C:TRP169
|
4.6
|
24.8
|
1.0
|
C11
|
C:R711630
|
4.7
|
55.8
|
0.4
|
F22
|
C:R711630
|
4.7
|
23.6
|
0.6
|
C
|
C:TRP169
|
4.8
|
24.8
|
1.0
|
O14
|
C:R711630
|
4.8
|
41.7
|
0.4
|
O14
|
C:R711630
|
4.8
|
41.7
|
0.6
|
CD2
|
C:PHE601
|
4.9
|
25.4
|
1.0
|
|
Reference:
A.Lenhart,
W.A.Weihofen,
A.E.W.Pleschke,
G.E.Schulz.
Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 Chem.Biol. V. 9 639 2002.
ISSN: ISSN 1074-5521
PubMed: 12031670
DOI: 10.1016/S1074-5521(02)00138-2
Page generated: Wed Jul 31 11:26:58 2024
|